Gaba-P 25 Capsule

About Gaba-P 25 Capsule

Gaba-P 25 is a 25 mg capsule containing pregabalin, made by Renata PLC. It is an adjunct anti-epileptic medicine also used in certain nerve pain conditions. The doctor decides the dose and course for each person.

There are 105 brands of Pregabalin listed in Bangladesh. The lowest listed price is GAPA-P 150 mg Capsule at ৳ 1 per unit.

What is Gaba-P 25 Capsule?

Gaba-P 25 is a capsule that contains pregabalin 25 mg. Pregabalin is related to a natural chemical in the body called GABA, though it does not act directly on GABA receptors; it binds to a site on calcium channels in the nervous system. It is grouped as an adjunct anti-epileptic drug, meaning it is used alongside other treatment. It is also used in some types of nerve pain and in fibromyalgia. Only a doctor can decide whether it suits a particular person, and the dose and course are set by the doctor.

Uses of Gaba-P 25

Gaba-P 25 is used for nerve pain linked to diabetic peripheral neuropathy, for postherpetic neuralgia, and for nerve pain after spinal cord injury. It is also used as add-on therapy for partial-onset seizures and for fibromyalgia. It is not a painkiller for everyday aches, and it should only be taken when a doctor has prescribed it for one of these conditions.

How to use Gaba-P 25

Take Gaba-P 25 exactly as the doctor tells you. Swallow the capsule as directed, and do not change the amount or stop it on your own, since the doctor sets the dose and course. If you miss a dose, ask your doctor or pharmacist what to do rather than guessing. Do not share it with anyone else. Tell your doctor about any other medicines you take, because some can interact with it.

Side effects of Gaba-P 25

Common side effects in adults include dizziness, drowsiness, dry mouth, swelling, blurred vision, weight gain, and trouble concentrating. In children treated for partial-onset seizures, increased weight and increased appetite are common. Swelling of the throat, head or neck, and allergic reactions such as hives, trouble breathing or wheezing, need urgent medical help. Contact your doctor if side effects bother you or do not settle.

Safety and precautions

Do not take Gaba-P 25 if you are allergic to pregabalin or any of its ingredients. Tell your doctor if you are pregnant, planning a pregnancy, or breastfeeding; small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Antiepileptic drugs including pregabalin can raise the risk of suicidal thoughts or behaviour, and breathing problems can occur when used with other central nervous system depressants or in people with breathing problems. Ask your doctor first if you have kidney problems or any other health condition.

Frequently asked questions

What does the generic name pregabalin mean?

Pregabalin is the generic name of the active ingredient in Gaba-P 25. It is a structural derivative of the body's GABA neurotransmitter, though it does not bind directly to GABA receptors. Knowing the generic name helps you compare products and check for allergies.

What is Gaba-P 25 used for and what kind of medicine is it?

It is an adjunct anti-epileptic drug, used as add-on therapy for partial-onset seizures. It is also used for certain nerve pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia and spinal cord injury pain, and for fibromyalgia. The doctor decides if it is suitable for you.

What do the capsule form and 25 mg strength mean?

Capsule describes the solid dosage form you swallow. The 25 mg strength means each capsule contains 25 mg of pregabalin. How much you take and for how long is decided by your doctor, not by the strength alone.

Can I stop taking Gaba-P 25 on my own?

No. Do not stop or change the dose without talking to your doctor first, as the doctor sets the dose and course. If you have side effects or want to stop, speak to your doctor or pharmacist, who will advise you on what to do.

Indications

Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
  • ... Read more
Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
Pregabalin CR tablet is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)

Pharmacology

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.

Dosage & Administration

Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.

Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).

Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.

Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).

Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.

Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.

Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
  • 75 mg/daily: 82.5 mg/day
  • 150 mg/daily: 165 mg/day
  • 225 mg/daily: 247.5 mg/day
  • 300 mg/daily: 330 mg/day
  • 450 mg/daily: 495 mg/day
  • 600 mg/daily: 660 mg/day

Interaction

Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.

Contraindications

Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.

Side Effects

Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.

Pregnancy & Lactation

There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.

Precautions & Warnings

Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.

Overdose Effects

In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.

Storage Conditions

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.

Alternative brands of Pregabalin

Other brands with the same generic name, cheapest first.

Gabarol Capsule

25 mg

Pregabalin

Advanced Chemical Industries PLC

৳ 11.00 per unit

Algaba Capsule

50 mg

Pregabalin

Al-Madina Pharmaceuticals Ltd.

৳ 12.00 per unit

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.